The DIXDC1 Knockout HEK293T Polyclonal Cells are a pool of human embryonic kidney epithelial cells in which the DIXDC1 gene has been disrupted by CRISPR/Cas9-mediated genome editing. This product is supplied as a polyclonal population, representing a heterogeneous collection of cells carrying diverse loss-of-function alleles at the target locus. Such polyclonal knockout models provide a robust system for investigating gene function while mitigating the risk of clonal adaptation artifacts that can arise from single-cell-derived lines. Researchers can immediately employ these cells in assays to assess the consequences of DIXDC1 ablation on cellular signaling, proliferation, and transformation-related phenotypes.
The parental HEK293T cell line is a widely utilized host for genetic manipulation and biochemical studies. Derived from HEK293 cells by stable integration of the SV40 large T antigen, HEK293T exhibits an adherent, epithelial morphology and a high proliferative capacity. Its exceptional transfection efficiency makes it the standard platform for recombinant protein expression, lentivirus production, and transient reporter assays. The epithelial origin of HEK293T cells further renders them suitable for modeling fundamental processes in epithelial biology, including junction formation, polarity, and signal transduction pathways that govern cell fate decisions.
DIXDC1 encodes a scaffold protein that functions as a positive regulator of the canonical Wnt/??-catenin signaling cascade. Through its DIX domain, DIXDC1 undergoes dynamic head-to-tail polymerization, facilitating the co-clustering of Dishevelled (DVL1, DVL2, DVL3) and Axin (AXIN1, AXIN2) into higher-order signalosomes. This molecular assembly is induced by Wnt ligands such as WNT3A and WNT1 that engage Frizzled receptors and LRP5/6 co-receptors. DIXDC1-mediated signalosome formation stabilizes ??-catenin by inhibiting the destruction complex, allowing ??-catenin to accumulate and translocate to the nucleus. There, it associates with TCF/LEF transcription factors to drive the expression of proliferative and oncogenic targets, including MYC, CCND1, and AXIN2. The pathway module can be summarized as WNT-FZD-DVL-DIXDC1-AXIN-??-catenin-TCF/LEF.
In HEK293T cells, the Wnt/??-catenin pathway is functionally intact, rendering this host an informative background for interrogating DIXDC1-dependent signaling events. Disruption of DIXDC1 in this context is expected to impair signalosome formation, leading to attenuated ??-catenin stabilization and reduced transcriptional output from TCF/LEF reporters. This knockout model thus enables dissection of the scaffolding role of DIXDC1 in fine-tuning Wnt signal strength. Given the implication of DIXDC1 in colorectal cancer, hepatocellular carcinoma, and neurodevelopmental disorders, this cell product serves as a relevant platform for oncogenic and developmental signaling studies. The polyclonal format provides biological averaging that better reflects the heterogeneous responses observed in tumor cell populations.
This knockout cell product is ideally suited for a spectrum of research applications in signal transduction and cancer biology. Investigators can employ these cells in Wnt pathway mechanistic studies using TOPFlash/FOPFlash luciferase reporter assays to quantify ??-catenin-driven transcription or perform western blotting and immunofluorescence to monitor ??-catenin stabilization and localization. Co-immunoprecipitation experiments can probe DIXDC1-DVL-Axin complex formation, while RT-qPCR enables quantification of downstream targets such as MYC and CCND1. High-throughput drug screening campaigns targeting the Wnt pathway, cell proliferation measurements via CCK-8 assays, and genetic rescue experiments are also highly feasible. For further details or customized solutions, please contact Ascent Research.
